TRDA Entrada Therapeutics, Inc.

Fundamentals / CIK 0001689375 / USD

Entrada Therapeutics, Inc. reported $3.98M in revenue and a net loss of $161.4M for the trailing twelve months ended September 30, 2026 (down 43.9% year over year), with a -4303.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TRDA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$222.9M$111.5M$0-$152.3MFY 2020 Net Income: -$26.52M2020FY 2021 Net Income: -$51.16M2021FY 2022 Net Income: -$94.62M2022FY 2023 Revenue: $129.0MFY 2023 Net Income: -$6.68M2023FY 2024 Revenue: $210.8MFY 2024 Net Income: $65.63M2024FY 2025 Revenue: $25.42MFY 2025 Net Income: -$143.8M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $25.42M $210.8M $129.0M -- -- --
Research & Development $142.3M $125.3M $99.88M $66.61M $35.93M $21.10M
Total Operating Expenses $183.3M $163.8M $132.2M $97.25M $51.13M $26.67M
Operating Income -$157.9M $47.01M -$3.16M -$97.25M -$51.13M -$26.67M
EBITDA -$153.8M $50.78M -$321K -$95.35M -$50.01M -$26.34M
Income Tax Expense $924K $859K $18.74M $0 $0 $0
Net Income -$143.8M $65.63M -$6.68M -$94.62M -$51.16M -$26.52M
Basic EPS -$3.47 $1.76 -$0.20 -$3.02 -$8.16 -$24.00
Diluted EPS -$3.47 $1.68 -$0.20 -$3.02 -$8.16 -$24.00
Basic Shares Outstanding 41.4M 37.3M 33.1M 31.3M 6.3M 1.1M
Diluted Shares Outstanding 41.4M 39.0M 33.1M 31.3M 6.3M 1.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $905K $898K $875K $1.30M $1.61M $1.95M $20.56M $37.40M
Research & Development $32.37M $35.37M $33.05M $33.96M $38.36M $37.88M $32.07M $33.41M
Total Operating Expenses $42.59M $45.86M $43.18M $43.51M $48.66M $48.80M $42.35M $43.27M
Operating Income -$41.69M -$44.96M -$42.30M -$42.21M -$47.05M -$46.85M -$21.79M -$5.87M
EBITDA -$40.99M -$44.16M -$41.50M -$41.32M -$45.85M -$45.75M -$20.84M -$4.88M
Income Tax Expense $27K $35K $38K $92K $654K $178K $0 -$1.87M
Net Income -$39.74M -$42.76M -$39.72M -$39.16M -$44.13M -$43.10M -$17.35M $1.13M
Basic EPS -$0.94 -$1.01 -$0.95 -- -$1.06 -$1.04 -$0.42 --
Diluted EPS -$0.94 -$1.01 -$0.95 -- -$1.06 -$1.04 -$0.42 --
Basic Shares Outstanding 42.4M 42.2M 41.8M -- 41.5M 41.3M 41.1M --
Diluted Shares Outstanding 42.4M 42.2M 41.8M -- 41.5M 41.3M 41.1M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $90.39M $101.2M $67.60M $45.16M $291.1M $39.05M
Short-Term Investments -- -- -- -- $0 --
Cash & Short-Term Investments $295.7M $420.0M $352.0M $188.7M $291.1M $39.05M
Total Current Assets $306.3M $440.0M $369.8M $209.9M $298.7M $39.95M
Property, Plant & Equipment, Net $7.31M $10.93M $11.19M $7.68M $6.26M $3.04M
Other Non-Current Assets $70K $284K $2.79M $5.21M $872K $541K
Total Non-Current Assets $71.13M $86.28M $99.42M $42.18M $7.13M $3.58M
Total Assets $377.4M $526.3M $469.2M $252.1M $305.8M $43.53M
Accounts Payable $2.29M $4.26M $3.28M $5.99M $706K $1.60M
Deferred Revenue (Current) $342K $13.65M $132.3M $0 -- --
Total Current Liabilities $24.45M $39.48M $158.8M $21.97M $6.72M $3.36M
Total Non-Current Liabilities $46.79M $58.16M $68.04M $17.53M $396K $0
Total Liabilities $71.25M $97.64M $226.8M $39.50M $7.12M $3.36M
Total Debt (incl. Leases) $50.93M $59.21M $68.23M $25.94M -- --
Common Stock $4.0K $4.0K $3.0K $3.0K $3.0K --
Retained Earnings -$273.1M -$129.3M -$195.0M -$188.3M -$93.67M -$42.51M
Accumulated Other Comp. Income $652K -$43K $195K -$2.06M $0 --
Total Stockholders' Equity $306.1M $428.7M $242.4M $212.6M $298.7M -$41.49M
Total Equity $306.1M $428.7M $242.4M $212.6M $298.7M -$41.49M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $112.2M $99.28M $76.44M $90.39M $93.29M $72.48M $67.84M $101.2M
Cash & Short-Term Investments $193.0M $223.0M $254.9M $295.7M $326.8M $354.0M $382.5M $420.0M
Total Current Assets $203.0M $232.7M $266.9M $306.3M $338.3M $369.1M $403.2M $440.0M
Property, Plant & Equipment, Net $5.21M $5.72M $6.51M $7.31M $8.41M $9.81M $10.67M $10.93M
Other Non-Current Assets $123K $118K $90K $70K $163K $199K $239K $284K
Total Non-Current Assets $63.93M $66.17M $68.65M $71.13M $74.64M $79.64M $83.29M $86.28M
Total Assets $266.9M $298.9M $335.5M $377.4M $412.9M $448.8M $486.5M $526.3M
Accounts Payable $4.87M $3.75M $2.93M $2.29M $3.17M $1.86M $2.19M $4.26M
Deferred Revenue (Current) $98K $173K $254K $342K $351K $689K $1.35M $13.65M
Total Current Liabilities $25.86M $21.37M $19.20M $24.45M $24.02M $19.80M $18.43M $39.48M
Total Non-Current Liabilities $42.69M $44.09M $45.47M $46.79M $48.16M $49.48M $50.79M $58.16M
Total Liabilities $68.56M $65.47M $64.66M $71.25M $72.18M $69.28M $69.22M $97.64M
Total Debt (incl. Leases) $47.31M $48.54M $49.75M $50.93M $52.40M $54.74M $57.00M $59.21M
Common Stock $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K $4.0K
Retained Earnings -$395.3M -$355.6M -$312.8M -$273.1M -$233.9M -$189.8M -$146.7M -$129.3M
Accumulated Other Comp. Income -$56K $66K $246K $652K $621K $400K $437K -$43K
Total Stockholders' Equity $198.3M $233.4M $270.9M $306.1M $340.7M $379.5M $417.3M $428.7M
Total Equity $198.3M $233.4M $270.9M $306.1M $340.7M $379.5M $417.3M $428.7M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$143.8M $65.63M -$6.68M -$94.62M -$51.16M -$26.52M
Depreciation & Amortization $4.10M $3.77M $2.84M $1.90M $1.12M $326K
Stock-Based Compensation $19.61M $17.91M $13.11M $9.89M $2.53M $325K
Change in Payables -$1.80M $991K -$2.81M $5.29M -$715K $631K
Operating Cash Flow -$128.5M -$41.56M $139.8M -$93.79M -$50.86M -$25.57M
Capital Expenditure -$1.04M -$3.16M -$5.61M -$2.89M -$4.58M -$2.32M
Free Cash Flow -$129.6M -$44.72M $134.2M -$96.67M -$55.44M -$27.89M
Purchases of Investments -$141.6M -$437.7M -$407.2M -$222.0M $0 --
Investing Cash Flow $116.8M -$27.80M -$138.4M -$148.7M -$4.58M -$2.32M
Financing Cash Flow $887K $103.0M $21.04M $479K $307.5M $50.09M
Net Change in Cash -$10.82M $33.61M $22.45M -$242.0M $252.0M $22.20M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$39.74M -$42.76M -$39.72M -$39.16M -$44.13M -$43.10M -$17.35M $1.13M
Depreciation & Amortization $700K $800K $805K $886K $1.20M $1.10M $946K $992K
Stock-Based Compensation $4.78M $5.15M $4.74M $4.36M $5.12M $5.05M $5.09M $4.70M
Change in Payables $1.12M $816K $641K -$877K $1.31M -$321K -$1.91M $2.85M
Operating Cash Flow -$29.96M -$32.46M -$41.70M -$32.20M -$28.31M -$29.49M -$38.51M -$31.61M
Capital Expenditure -$161K -$11K -$44K $207K $171K -$275K -$1.14M -$635K
Free Cash Flow -$30.12M -$32.47M -$41.74M -$32.00M -$28.14M -$29.76M -$39.65M -$32.24M
Purchases of Investments -$7.92M -$3.92M -$11.82M -$18.47M -$26.57M -$16.55M -$80.02M -$64.50M
Investing Cash Flow $42.92M $54.95M $26.99M $29.12M $49.11M $33.80M $4.78M $53.37M
Financing Cash Flow $0 $350K $100K $192K $8.0K $337K $350K $1.40M
Net Change in Cash $12.96M $22.84M -$14.61M -$2.89M $20.80M $4.64M -$33.37M $23.16M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -621.1% 22.3% -2.5% -- -- --
Net Profit Margin -565.5% 31.1% -5.2% -- -- --
Return on Equity (ROE) -47.0% 15.3% -2.8% -44.5% -17.1% --
Return on Assets (ROA) -38.1% 12.5% -1.4% -37.5% -16.7% -60.9%
Current Ratio 12.53x 11.15x 2.33x 9.55x 44.46x 11.89x
Quick Ratio 12.09x 10.64x 2.22x 8.59x 43.32x 11.62x
Debt to Equity 0.17x 0.14x 0.28x 0.12x -- --
Revenue Growth (YoY) -87.9% +63.4% -- -- -- --
Operating Income Growth (YoY) -435.9% -- -- -- -- --
Net Income Growth (YoY) -319.0% -- -- -- -- --
EPS Growth (YoY) -297.2% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -129.7% -- -- -- --
Free Cash Flow Growth (YoY) -- -133.3% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -4303.8% -3767.1% -3109.3% -621.1% -197.6% -121.0% 2.4% 22.3%
Net Profit Margin -4058.0% -3537.7% -2895.1% -565.5% -168.2% -92.3% 14.4% 31.1%
Return on Equity (ROE) -81.4% -71.0% -61.3% -47.0% -30.4% -19.3% 5.9% 15.3%
Return on Assets (ROA) -60.5% -55.5% -49.5% -38.1% -25.1% -16.3% 5.1% 12.5%
Current Ratio 7.85x 10.89x 13.90x 12.53x 14.08x 18.64x 21.88x 11.15x
Quick Ratio 7.46x 10.43x 13.28x 12.09x 13.61x 17.88x 20.75x 10.64x
Debt to Equity 0.24x 0.21x 0.18x 0.17x 0.15x 0.14x 0.14x 0.14x
Revenue Growth (YoY) -43.9% -53.9% -95.7% -96.5% -91.8% -97.9% -65.2% -10.6%
Operating Income Growth (YoY) -- -- -- -- -- -187.7% -203.2% -219.6%
Net Income Growth (YoY) -- -- -- -3562.8% -- -178.3% -173.8% --
EPS Growth (YoY) -- -- -- -- -- -164.6% -160.0% --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -174.0% -- --
Free Cash Flow Growth (YoY) -- -- -- -- -- -176.7% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001689375) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:44 UTC · Open in terminal